LINC01140

Across TCGA pan-cancer cohorts, LINC01140 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC01140 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC01140 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC01140 expression acts as an unfavorable survival marker, although some lineages such as UCS and SARC show a favorable association.

UCS, UVM, and LIHC are the cancer types where LINC01140 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	II,III,IV	0.668	0.227	<.001	112	view →
UVM	DFS	Quartile	All	0.439	0.836	<.001	64	view →
LIHC	OS	Tertile	All	0.579	0.777	.001	39	view →
UCEC	DFS	Tertile	All	0.547	0.684	<.001	38	view →
KIRP	DFS	Median	All	0.590	0.938	.005	32	view →
BLCA	DFS	Tertile	II,III,IV	0.431	0.555	.010	27	view →
THCA	OS	Tertile	All	0.973	0.999	.015	21	view →
ACC	DFS	Median	IV	0.188	0.506	.005	18	view →
SARC	DFS	Tertile	All	0.465	0.200	<.001	18	view →
BRCA	OS	Tertile	All	0.975	0.944	.024	13	view →
ESCA	OS	Quartile	All	0.790	0.567	.027	12	view →
STAD	OS	Quartile	All	0.396	0.585	.025	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC01140–UCS (DFS)

Open the UCS breakdown →